Jiangsu Hengrui Medicine\'s PD1 antibody camrelizumab is said to receive approval in China on May 5 per local media reports; marks 5 PDL1 drug OKed in the market. Sina Health httpsmp.weixin.qq.comsLA5j0ybhzBL7WZPdTRdaPwÂSohuhttpww

Jiangsu #Hengrui Medicine's #PD-1 antibody camrelizumab is said to receive approval in China on May 5, per local media reports; marks #5 PD-(L)1 drug OKed in the market. Sina Health: https://mp.weixin.qq.com/s/LA5j0ybhzBL7WZPdTRdaPw … Sohu:http://ww

23:03 EDT 5 May 2019 | Brad Loncar

Jiangsu #Hengrui Medicine's #PD-1 antibody camrelizumab is said to receive approval in China on May 5, per local media reports; marks #5 PD-(L)1 drug OKed in the market. Sina Health: https://mp.weixin.qq.com/s/LA5j0ybhzBL7WZPdTRdaPw … Sohu: http://www.sohu.com/a/311980708_114988 …